EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis

Debora M Meijer iD, Dina Ruano, Inge H Briaire-de Bruijn, Pauline M Wijers-Koster, Michiel A J van de Sande, Hans Gelderblom, Anne-Marie Cleton-Jansen, Noel F C C de Miranda, Marieke L Kuijjer iD, Judith V M G Bovée iD

Genes, Chromosomes and Cancer · 2024-07 · 63 (7)

DOI: 10.1002/gcc.23253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, online erschienen am 18.07.2024. Verfasst von Debora M Meijer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Osteosarcoma, DNA Copy Number Variations, Bone Neoplasms, Disease Progression. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural Leiden Center for Computational Oncology Strategic Fund, Norwegian Research Council, Helse Sør-Øst and the University of Oslo through the Centre for Molecular Medicine Norway, Norwegian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma is a primary bone tumor that exhibits a complex genomic landscape characterized by gross chromosomal abnormalities. Osteosarcoma patients often develop metastatic disease, resulting in limited therapeutic options and poor survival rates. To gain knowledge on the mechanisms underlying osteosarcoma heterogeneity and metastatic process, it is important to obtain a detailed profile of the genomic alterations that accompany osteosarcoma progression. We performed WGS on multiple tissue samples from six patients with osteosarcoma, including the treatment naïve biopsy of the primary tumor, resection of the primary tumor after neoadjuvant chemotherapy, local recurrence, and distant metastases. A comprehensive analysis of single‐nucleotide variants (SNVs), structural variants, copy number alterations (CNAs), and chromothripsis events revealed the genomic heterogeneity during osteosarcoma progression. SNVs and structural variants were found to accumulate over time, contributing to an increased complexity of the genome of osteosarcoma during disease progression. Phylogenetic trees based on SNVs and structural variants reveal distinct evolutionary patterns between patients, including linear, neutral, and branched patterns. The majority of osteosarcomas showed variable copy number profiles or gained whole‐genome doubling in later occurrences. Large proportions of the genome were affected by loss of heterozygosity (LOH), although these regions remain stable during progression. Additionally, chromothripsis is not confined to a single early event, as multiple other chromothripsis events may appear in later occurrences. Together, we provide a detailed analysis of the complex genome of osteosarcomas and show that five of six osteosarcoma genomes are highly dynamic and variable during progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaDNA Copy Number VariationsBone NeoplasmsDisease ProgressionHumansMaleFemaleAdultPolymorphism, Single NucleotideLoss of HeterozygosityWhole Genome SequencingChromothripsisAdolescentGenome, Human

Stichwörter der Autor:innen

disease progressiongenomicsheterogeneityosteosarcomawhole‐genome sequencing

Autor:innen und Institutionen

  • Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Leiden Center for Computational Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Orthopaedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo, Oslo, Norway.

ORCID-Profile: Debora M Meijer, Marieke L Kuijjer, Judith V M G Bovée

Förderung

  • Intramural Leiden Center for Computational Oncology Strategic Fund
  • Norwegian Research Council, Helse Sør-Øst and the University of Oslo through the Centre for Molecular Medicine Norway
  • Norwegian Research Council
  • Norwegian Cancer Society
  • European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Program
  • VIDI ZonMW grant by NWO
  • Norges Forskningsråd
  • Kreftforeningen

Zitieren

APA

Meijer, D. M., Ruano, D., Briaire-de Bruijn, I. H., Wijers-Koster, P. M., van de Sande, M. A. J., Gelderblom, H., Cleton-Jansen, A. M., de Miranda, N. F. C. C., Kuijjer, M. L., & Bovée, J. V. M. G. (2024). The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis. Genes, Chromosomes and Cancer, 63(7). https://doi.org/10.1002/gcc.23253

Vancouver

Meijer DM, Ruano D, Briaire-de Bruijn IH, Wijers-Koster PM, van de Sande MAJ, Gelderblom H, et al. The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis. Genes, Chromosomes and Cancer. 2024;63(7). doi:10.1002/gcc.23253

BibTeX
@article{Meijer2024,
  author = {Meijer, Debora M and Ruano, Dina and Briaire-de Bruijn, Inge H and Wijers-Koster, Pauline M and van de Sande, Michiel A J and Gelderblom, Hans and Cleton-Jansen, Anne-Marie and de Miranda, Noel F C C and Kuijjer, Marieke L and Bovée, Judith V M G},
  title = {The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis},
  journal = {Genes, Chromosomes and Cancer},
  year = {2024},
  volume = {63},
  number = {7},
  doi = {10.1002/gcc.23253}
}
Kostenlos starten →